Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.
暂无分享,去创建一个
A. Holland | C. McDonald | C. Hill | A. Lee | M. Naughton | T. Rasekaba
[1] Ron D. Hays,et al. The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research , 2012, PharmacoEconomics.
[2] A. Holland,et al. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. , 2009, Respiratory medicine.
[3] A. Holland,et al. The six‐minute walk test: a useful metric for the cardiopulmonary patient , 2009, Internal medicine journal.
[4] G. Guyatt,et al. Interpretation of treatment changes in 6-minute walk distance in patients with COPD , 2008, European Respiratory Journal.
[5] B. Celli,et al. Validation and comparison of reference equations for the 6-min walk distance test , 2008, European Respiratory Journal.
[6] Thierry Troosters,et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.
[7] S. Studenski,et al. Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults , 2006, Journal of the American Geriatrics Society.
[8] N. Okudan,et al. Single Dose of Tiotropium Improves the 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease , 2006, Lung.
[9] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[10] G. Guyatt,et al. Commentary--goodbye M(C)ID! Hello MID, where do you come from? , 2005, Health services research.
[11] A. Holland,et al. Does unsupported upper limb exercise training improve symptoms and quality of life for patients with chronic obstructive pulmonary disease? , 2004, Journal of cardiopulmonary rehabilitation.
[12] B. Celli,et al. The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.
[13] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[14] B. Celli,et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. , 2002, Chest.
[15] D. Beaton,et al. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. , 2002, Current opinion in rheumatology.
[16] W M Tierney,et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.
[17] E. Weitzenblum,et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[18] M. Marmot,et al. Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study , 1997, BMJ.
[19] D A Redelmeier,et al. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.
[20] G H Guyatt,et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.
[21] R. Tibshirani,et al. An Introduction to the Bootstrap , 1995 .
[22] R A Deyo,et al. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.
[23] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[24] Lewis E. Kazis,et al. Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.
[25] G. Guyatt,et al. Measuring change over time: assessing the usefulness of evaluative instruments. , 1987, Journal of chronic diseases.